-
We might need to redefine our approach to drug discovery and approval to be prepared for the future
expresspharma
January 08, 2021
Hitesh Windlass, MD, Windlas Biotech gives an overview of the changes bought by COVID-19 pandemic in the pharma industry, his organisation’s plans for future growth and more, in an interview with Lakshmpriya Nair.
-
Trane Technologies’ Thermo King launches cold chain solutions for COVID-19 vaccines in India
expresspharma
January 06, 2021
Thermo King’s SuperFreezers offer transport and storage of vaccines from a pharma company to the inoculation site by maintaining temperatures from +25° C to -70° C .
-
Pharma industry urges government to extend MEIS scheme till March 2021
expresspharma
December 28, 2020
Since April 2020, the Indian pharma industry is facing a challenge in availing the MEIS benefits.
-
India has key role to play in equitable distribution of COVID-19 vaccines: Industry experts
expresspharma
December 28, 2020
With vaccine rollout beginning in some countries, the world ravaged by the COVID-19 pandemic is looking to India for the large-scale production and supply of coronavirus vaccines as it enters 2021.
-
India likely to approve AstraZeneca vaccine by next week – sources
expresspharma
December 23, 2020
AstraZeneca-Oxford shot is considered vital for lower-income countries and those in hot climates.
-
India to make 300 million Sputnik V vaccines
expresspharma
December 21, 2020
India will produce about 300 million doses of Russia’s Sputnik V coronavirus vaccines next year, a Russian official was quoted as saying, nearly three times the previously known number as deals have been signed with more manufacturers.
-
Dun & Bradstreet – Amex nominate Neelikon under ‘Leading Mid-Corporates of India 2020’
expresspharma
December 21, 2020
Two publications listing and profiling the leading SMEs and mid corporates in India, were released by Nitin Gadkari at a virtual event ‘Business Enterprises of Tomorrow 2020’, hosted by Dun & Bradstreet - American Express Banking Corp recently.
-
NATCO launches Rivaroxaban¸ anticoagulant medication in India
expresspharma
December 18, 2020
Natco Pharma announced the launch of Rivaroxaban molecule, under brand RPIGAT. Rivaroxaban is an anticoagulant medication used to treat and prevent blood clots. Rivaroxaban is currently sold by Bayer under the brand name of Xarelto, in the Indian market.
-
Australia invests AUSD 4 mn for research with India on COVID-19
expresspharma
December 14, 2020
Apart from new technologies for early detection of COVID-19, the researchers are focusing on the longer-term effects of the virus on the heart and lungs of patients who have recovered.
-
India prepares for 600 mn COVID vaccine shots; to use standard cold storage: VK Paul
expresspharma
December 14, 2020
India will deploy its vast election machinery to deliver 600 million doses of COVID-19 vaccines to the most vulnerable people in the next six to eight months through conventional cold chain systems, said Dr VK Paul, the expert leading the initiative.